The purpose of this study is to determine whether influenza vaccination protects patients who receive a certain type of bone marrow transplantation.
Patients who receive bone marrow transplantation are at high risk for complications from influenza infection. It is not whether influenza vaccination protects patients who undergo a type of bone marrow transplantation called "nonmyeloablative", or "reduced intensity" bone marrow transplantation. This study compares the response to influenza vaccination in a group of these patients to that in healthy people.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
36
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Is the influenza vaccine immunogenic in patients receiving nonmyeloabalative allogeneic PBSCT compared to healthy controls as judged by their humoral antibody response?
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.